UNSPSC 51341802: Oseltamivir

This classification denotes an antiviral agent with the molecular formula C16H28N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 20O93L6F9H, chemically known as 1-cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3r,4r,5s)- but generally known as oseltamivir, which bears US NIH Compound Identifier 65028. European Medicines Agency schedules Oseltamivir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03553MIG.

UNSPSC 51341802 Oseltamivir, a Commodity code, covers pharmaceutical products that state and local governments procure through public health and emergency-preparedness channels, though recent activity under this specific code shows minimal directly relevant solicitation volume. The code nominally represents oseltamivir (Tamiflu) — an antiviral medication — but the two most recent state and local opportunities posted against it involve different pharmaceuticals entirely: one an Illinois Department of Public Health piggyback award for Doxycycline Hyclate and Ciprofloxacin Hydrochloride through the MMCAP Infuse cooperative purchasing vehicle, and the other a Seminole County, Florida procurement for Naloxone and drug deactivation systems. This mismatch suggests the code may serve as a catchall tag for pharmaceutical inventory management and emergency-response drug stockpiling rather than oseltamivir-specific procurement.

Recent activity is limited to two opportunities across two states. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract to Chartwell Rx LLC through an IFB process on August 28, 2026, supplying antibiotics to state stockpile over a 12-month initial term with renewal options for years 2 and 3. Seminole County, Florida issued an IFB (solicitation IFB60459723LAS) posted June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly delivery to the county community health building; the response deadline was July 26, 2023 (a date conflict in the source), and the contract included a two-year initial term with one-year renewal option. Neither opportunity shows set-asides for small, minority, women, or veteran-owned businesses. The geographic spread is narrow — Illinois and Florida — and the issuing-body mix favors state public health departments and county health authorities. Cooperative purchasing vehicles such as MMCAP Infuse appear to drive state procurement under this code.